Millennium Management’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,561
| Closed | -$39.2K | – | 3995 |
|
|
2024
Q4 | $39.2K | Sell |
6,561
-1,487
| -18% | -$8.9K | ﹤0.01% | 3919 |
|
|
2024
Q3 | $78.6K | Buy |
8,048
+376
| +5% | +$3.67K | ﹤0.01% | 3876 |
|
|
2024
Q2 | $157K | Buy |
7,672
+4,852
| +172% | +$99.4K | ﹤0.01% | 3636 |
|
|
2024
Q1 | $127K | Sell |
2,820
-2,677
| -49% | -$121K | ﹤0.01% | 3775 |
|
|
2023
Q4 | $259K | Sell |
5,497
-3,714
| -40% | -$175K | ﹤0.01% | 3455 |
|
|
2023
Q3 | $373K | Buy |
+9,211
| New | +$373K | ﹤0.01% | 3383 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 4256 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 4560 |
|
|
2022
Q3 | – | Sell |
-11,784
| Closed | -$2.49M | – | 5159 |
|
|
2022
Q2 | $2.49M | Buy |
11,784
+10,572
| +872% | +$2.23M | ﹤0.01% | 2703 |
|
|
2022
Q1 | $405K | Buy |
1,212
+9
| +0.7% | +$3.01K | ﹤0.01% | 4214 |
|
|
2021
Q4 | $391K | Buy |
+1,203
| New | +$391K | ﹤0.01% | 4192 |
|
|
2021
Q2 | – | Sell |
-912
| Closed | -$630K | – | 5002 |
|
|
2021
Q1 | $630K | Sell |
912
-2,910
| -76% | -$2.01M | ﹤0.01% | 3526 |
|
|
2020
Q4 | $2.83M | Sell |
3,822
-1,373
| -26% | -$1.01M | ﹤0.01% | 2282 |
|
|
2020
Q3 | $3.6K | Buy |
5,195
+3,122
| +151% | +$2.17K | ﹤0.01% | 1639 |
|
|
2020
Q2 | $1.76M | Buy |
+2,073
| New | +$1.76M | ﹤0.01% | 2099 |
|
|
2019
Q2 | – | Sell |
-804
| Closed | -$127K | – | 3497 |
|
|
2019
Q1 | $127K | Buy |
+804
| New | +$127K | ﹤0.01% | 3276 |
|
|
2018
Q3 | – | Sell |
-2,862
| Closed | -$421K | – | 3500 |
|
|
2018
Q2 | $421K | Buy |
2,862
+931
| +48% | +$137K | ﹤0.01% | 2882 |
|
|
2018
Q1 | $316K | Buy |
+1,931
| New | +$316K | ﹤0.01% | 2960 |
|